[144] IonQ, Inc. SEC Filing

Rhea-AI Filing Summary

IONQ insider plans to sell common stock under Rule 144. A holder has filed a notice to sell 100,000 shares of IONQ common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $4,788,000 based on the pricing used in the notice. The filing states that 354,279,591 shares of IONQ common stock were outstanding at the time referenced. The securities were acquired as restricted stock units from the issuer on December 10, 2023, and fully vested on that date for this amount. Over the past three months, the same seller disposed of 19,976 common shares for gross proceeds of $886,966.36. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about IONQ’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	100000	4788000.00	354279591	11/20/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2023	Restricted Stock Units	Issuer			100000	12/10/2023	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RIMA ALAMEDDINE 4505 Campus Drive College Park MD 20740	Common	09/11/2025	19976	886966.36

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the IONQ Form 144 filing disclose?

The Form 144 filing for IONQ discloses that a holder intends to sell 100,000 shares of IONQ common stock under Rule 144 through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $4,788,000.00 based on the filing figures.

How many IONQ shares are covered by this planned Rule 144 sale?

The notice covers a proposed sale of 100,000 shares of IONQ common stock. These shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, as listed in the Rule 144 filing.

What is the stated market value of the IONQ shares to be sold?

The filing reports an aggregate market value for the planned sale of $4,788,000.00 for the 100,000 IONQ common shares referenced in the Form 144 notice.

How many IONQ shares were outstanding according to the filing?

The Form 144 indicates that 354,279,591 shares of IONQ common stock were outstanding at the time referenced in the notice; this is a baseline share count for the company.

When were the IONQ shares being sold originally acquired and how?

The 100,000 IONQ common shares to be sold were acquired on 12/10/2023 as restricted stock units from the issuer, with the consideration described as N/A in the table, indicating no separate cash purchase at that time.

Has this IONQ insider sold shares recently before this notice?

Yes. Over the past three months, the seller Rima Alameddine sold 19,976 IONQ common shares on 09/11/2025 for $886,966.36 in gross proceeds, as disclosed in the same Form 144.

What representation does the seller make about IONQ in this Form 144?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know of any material adverse information about the current or prospective operations of IONQ that has not been publicly disclosed.